Inflammatory mechanisms of progression in Multiple Sclerosis

Multiple sclerosis is a chronic disease of the central nervous system and the most common neurological disability in young adults. While effective treatments are available to prevent acute relapses, these therapies often fail to halt the insidious progression of the disease. This is precisely where the new research project comes in. The brain and spinal cord are surrounded by a protective fluid called cerebrospinal fluid. This fluid acts as an interface between the body`s immune system and the central nervous system. In multiple sclerosis patients, inflammatory cells accumulate in this fluid, potentially driving disease progression. In this project, different patient groups will be studied: those experiencing acute relapses and those with slowly progressing disease. By analyzing the cerebrospinal fluid using state-of-the- art molecular biology techniques, the project aims to identify which inflammatory cells play a role in which form of the disease. What makes this project particularly innovative is its approach: rather than taking samples just once, the fluid will be repeatedly examined over an extended period. This allows tracking how inflammatory processes develop over time. These results will then be compared with high- resolution magnetic resonance imaging scans of the brain and validated through examination of tissue samples from deceased patients. The insights from this project could be groundbreaking for developing new, targeted therapies against multiple sclerosis progression. Furthermore, they could contribute to developing better monitoring methods that allow doctors to track disease progression more precisely. This would ultimately lead to improved quality of life for the many affected patients. The unique combination of well-defined clinical patient groups, cutting-edge technologies for spinal fluid examination, and post-mortem validation represents an unprecedented approach in multiple sclerosis research. By understanding the specific inflammatory processes occurring in the cerebrospinal fluid, the project hopes to unlock new therapeutic targets and provide patients with more effective treatment options in the future.